Abstract
Abstract Autocleavage assay and peptide‐based cleavage assay were used to study the substrate specificity of 3CL protease from the severe acute respiratory syndrome coronavirus. It was found that the recognition between the enzyme and its substrates involved many positions in the substrate, at least including residues from P4 to P2′. The deletion of either P4 or P2′ residue in the substrate would decrease its cleavage efficiency dramatically. In contrast to the previous suggestion that only small residues in substrate could be accommodated to the S1′ subsite, we have found that bulky residues such as Tyr and Trp were also acceptable. In addition, based on both peptide‐based assay and autocleavage assay, Ile at the P1′ position could not be hydrolyzed, but the mutant L27A could hydrolyze the Ile peptide fragment. It suggested that there was a stereo hindrance between the S1′ subsite and the side chain of Ile in the substrate. All 20 amino acids except Pro could be the residue at the P2′ position in the substrate, but the cleavage efficiencies were clearly different. The specificity information of the enzyme is helpful for potent anti‐virus inhibitor design and useful for other coronavirus studies.
Edited by Ming‐Hua XU
Keywords: SARS coronavirus 3CL protease, substrate specificity, autocleavage, binding site, inhibitor design
This work was supported by a grant from the National Natural Science Foundation of China (No. 39930060)
References
- 1. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300: 1394–1399. [DOI] [PubMed] [Google Scholar]
- 2. Holmes KV, Enjuanes L. The SARS coronavirus: Apostgenomic era. Science 2003, 300: 1377–1378. [DOI] [PubMed] [Google Scholar]
- 3. Ziebuhr, J , Snijder, EJ , Gorbalenya, AE. Virus‐encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol 2000, 81: 853–879. [DOI] [PubMed] [Google Scholar]
- 4. Anand K, Palm GJ, Mesters JR, Siddell SG, Ziebuhr J, Hilgenfeld R. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α‐helical domain. EMBO J 2002, 21: 3213–3224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Palmenberg AC. Proteolytic processing of picornaviral polyprotein. Annu Rev Microbiol 1990, 44: 603–623. [DOI] [PubMed] [Google Scholar]
- 6. Kiemer L, Lund O, Brunak S, Blom N. Coronavirus 3CLpro proteinase cleavage sites: Possible relevance to SARS virus pathology. BMC Bioinformatics 2004, 5: 72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Hegyi A, Ziebuhr J. Conservation of substrate specificities among coronavirus main proteases. J Gen Virol 2002, 83: 595–599. [DOI] [PubMed] [Google Scholar]
- 8. Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: Basis for design of anti‐SARS drugs. Science 2003, 300: 1763–1767. [DOI] [PubMed] [Google Scholar]
- 9. Fan K, Wei P, Feng Q, Chen S, Huang C, Ma L, Lai B et al. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C‐like proteinase. J Biol Chem 2004, 279: 1637–1642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Yang H, Yang M, Ding Y, Liu Y, Lou Z, Zhou Z, Sun L et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci USA 2003, 100: 13190–13195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Shan YF, Li SF, Xu GJ. A novel auto‐cleavage assay for studying mutational effects on the active site of severe acute respiratory syndrome coronavirus 3C‐like protease. Biochem Biophys Res Commun 2004, 324: 579–583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Cordingley MG, Callahan, PL , Sardana, VV , Garsky VM, Colonno RJ. Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro. J Biol Chem 1990, 265: 9062–9065. [PubMed] [Google Scholar]
- 13. Schechter I, Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 1967, 27: 157–162. [DOI] [PubMed] [Google Scholar]
- 14. Sun H, Luo H, Yu C, Sun T, Chen J, Peng S, Qin J et al. Molecular cloning, expression, purification, and mass spectrometric characterization of 3C‐like protease of SARS coronavirus. Protein Expr Purif 2003, 32: 302–308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Wirblich C, Sibilia M, Boniotti MB, Rossi C, Thiel HJ, Meyers G. 3C‐like protease of rabbit hemorrhagic disease virus: Identification of cleavage sites in the ORF1 polyprotein and analysis of cleavage specificity. J Virol 1995, 69: 7159–7168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Hsu WC, Chang HC, Chou CY, Tsai PJ, Lin PI, Chang GG. Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease. J Biol Chem 2005, 280: 22741–22748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Ziebuhr J, Heusipp G, Siddell SG. Biosynthesis, purification, and characterization of the human coronavirus 229E 3C‐like proteinase. J Virol 1997, 71: 3992–3997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Shi J, Wei Z, Song J. Dissection study on the severe acute respiratory syndrome 3C‐like protease reveals the critical role of the extra domain in dimerization of the enzyme: Defining the extra domain as a new target for design of highly specific protease inhibitors. J Biol Chem 2004, 279: 24765–24773. [DOI] [PMC free article] [PubMed] [Google Scholar]